COVID-19 and Your Health. CDC (11 February 2020). Alirita 23 March 2021. “To prevent the spread of germs, including COVID-19, CDC recommends washing hands with soap and water whenever possible because it reduces the amount of many types of germs and chemicals on hands. But if soap and water are not readily available, using a hand sanitizer with at least 60% alcohol can help you avoid getting sick and spreading germs to others.”.
(April 2021) “Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients”, PLOS ONE16 (4), p. e0249788. doi:10.1371/journal.pone.0249788.
(November 2020) “Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients”, Frontiers in Neurology11, p. 562634. doi:10.3389/fneur.2020.562634.
(April 2021) “Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients”, The Laryngoscope131 (4), p. 865–878. doi:10.1002/lary.29286.
(November 2020) “Prevalence and Characteristics of Taste Disorders in Cases of COVID-19: A Meta-analysis of 29,349 Patients”, Otolaryngology–Head and Neck Surgery165 (1), p. 33–42. doi:10.1177/0194599820981018.
(January 2021) “The Proportion of SARS-CoV-2 Infections That Are Asymptomatic : A Systematic Review”, Annals of Internal Medicine174 (5), p. M20–6976. doi:10.7326/M20-6976.
(23 June 2020) “The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries”, PLOS ONE15 (6), p. e0234765. doi:10.1371/journal.pone.0234765.
(December 2020) “Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects”, Otolaryngology–Head and Neck Surgery163 (6), p. 1144–1149. doi:10.1177/0194599820939538.
(September 2021) “Turmeric as a Possible Treatment for COVID-19-Induced Anosmia and Ageusia”, Cureus13 (9), p. e17829. doi:10.7759/cureus.17829.
(July 2020) “The neurological manifestations of COVID-19: a review article”, Neurological Sciences41 (7), p. 1667–1671. doi:10.1007/s10072-020-04486-3.
(February 2021) “A systematic review of asymptomatic infections with COVID-19”, Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi54 (1), p. 12–16. doi:10.1016/j.jmii.2020.05.001.
(June 2020) “Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths”, Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi53 (3), p. 404–412. doi:10.1016/j.jmii.2020.02.012.
(July 2020) “Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic”, Emerging Infectious Diseases26 (7). doi:10.3201/eid2607.201595.
(October 2020) “Mild or Moderate Covid-19”, The New England Journal of Medicine383 (18), p. 1757–1766. doi:10.1056/NEJMcp2009249.
(May 2021) “Ten scientific reasons in support of airborne transmission of SARS-CoV-2”, Lancet397 (10285), p. 1603–1605. doi:10.1016/s0140-6736(21)00869-2.
(2 June 2020) “The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission”, Proceedings of the National Academy of Sciences117 (22), p. 11875–11877. doi:10.1073/pnas.2006874117.
(March 2021) “Transmission of SARS-CoV-2 by inhalation of respiratory aerosol in the Skagit Valley Chorale superspreading event”, Indoor Air31 (2), p. 314–323. doi:10.1111/ina.12751.
(January 2021) “Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors”, Annals of Internal Medicine174 (1), p. 69–79. doi:10.7326/M20-5008.
(October 2020) “Cluster infections play important roles in the rapid evolution of COVID-19 transmission: A systematic review”, International Journal of Infectious Diseases99, p. 374–380. doi:10.1016/j.ijid.2020.07.073.
(April 2020) “The proximal origin of SARS-CoV-2”, Nature Medicine26 (4), p. 450–452. doi:10.1038/s41591-020-0820-9.
(February 2020) “A Novel Coronavirus from Patients with Pneumonia in China, 2019”, The New England Journal of Medicine382 (8), p. 727–733. doi:10.1056/NEJMoa2001017.
(August 2020) “Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview”, Pathogens and Disease78 (6). doi:10.1093/femspd/ftaa042.
(2020) “The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET”, Pathogens & Immunity5 (1), p. 342–363. doi:10.20411/pai.v5i1.377.
(December 2020) “Coronavirus vaccine development: from SARS and MERS to COVID-19”, Journal of Biomedical Science27 (1), p. 104. doi:10.1186/s12929-020-00695-2.
(July 2021) “The success of SARS-CoV-2 vaccines and challenges ahead”, Cell Host & Microbe29 (7), p. 1111–1123. doi:10.1016/j.chom.2021.06.016.
(December 2020) “Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis”, BMJ371, p. m4750. doi:10.1136/bmj.m4750.
(April 2020) “Face masks for the public during the covid-19 crisis”, BMJ369, p. m1435. doi:10.1136/bmj.m1435.
(July 2020) “Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission”, The Lancet. Respiratory Medicine8 (7), p. 658–659. doi:10.1016/S2213-2600(20)30245-9.
(May 2020) “COVID-19 and social distancing”, Zeitschrift Fur Gesundheitswissenschaften = Journal of Public Health, p. 1–3. doi:10.1007/s10389-020-01321-z.
(August 2020) “Exaggerated risk of transmission of COVID-19 by fomites”, The Lancet. Infectious Diseases20 (8), p. 892–893. doi:10.1016/S1473-3099(20)30561-2.
(November 2020) “Infectivity of SARS-CoV-2 and Other Coronaviruses on Dry Surfaces: Potential for Indirect Transmission”, Materials13 (22), p. 5211. doi:10.3390/ma13225211.
(November 2020) “How coronavirus survives for days on surfaces”, Physics of Fluids32 (11), p. 111706. doi:10.1063/5.0033306.
(February 2021) “Why coronavirus survives longer on impermeable than porous surfaces”, Physics of Fluids33 (2), p. 021701. doi:10.1063/5.0037924.
(April 2021) “Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients”, British Journal of Sports Medicine. doi:10.1136/bjsports-2021-104080.
(December 2020) “Mechanisms of SARS-CoV-2 Transmission and Pathogenesis”, Trends in Immunology41 (12), p. 1100–1115. doi:10.1016/j.it.2020.10.004.
(June 2020) “The pivotal link between ACE2 deficiency and SARS-CoV-2 infection”, European Journal of Internal Medicine76, p. 14–20. doi:10.1016/j.ejim.2020.04.037.
(April 2020) “Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses”, Nature Microbiology5 (4), p. 562–569. doi:10.1038/s41564-020-0688-y.
(May 2020) “COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission”, Gastroenterology158 (6), p. 1518–1519. doi:10.1053/j.gastro.2020.02.054.
(May 2020) “COVID-19, coronavirus, SARS-CoV-2 and the small bowel”, Revista Espanola de Enfermedades Digestivas112 (5), p. 383–388. doi:10.17235/reed.2020.7137/2020.
(May 2020) “COVID-19 and the cardiovascular system”, Nature Reviews. Cardiology17 (5), p. 259–260. doi:10.1038/s41569-020-0360-5.
(February 2020) “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”, Lancet395 (10223), p. 497–506. doi:10.1016/S0140-6736(20)30183-5.
(June 2004) “ACE2: from vasopeptidase to SARS virus receptor”, Trends in Pharmacological Sciences25 (6), p. 291–4. doi:10.1016/j.tips.2004.04.001.
(October 2020) “The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management”, Thrombosis Research194, p. 101–115. doi:10.1016/j.thromres.2020.06.029.
(April 2020) “How does coronavirus kill? Clinicians trace a ferocious rampage through the body, from brain to toes”, Science. doi:10.1126/science.abc3208.
(July 2021) “Physical phenotype of blood cells is altered in COVID-19”, Biophysical Journal120 (14), p. 2838–2847. doi:10.1016/j.bpj.2021.05.025.
(November 2020) “Lifting the mask on neurological manifestations of COVID-19”, Nature Reviews. Neurology16 (11), p. 636–644. doi:10.1038/s41582-020-0398-3.
(2020) “COVID 19-Induced Smell and Taste Impairments: Putative Impact on Physiology”, Frontiers in Physiology11, p. 625110. doi:10.3389/fphys.2020.625110.
(November 2020) “Laboratory diagnosis of coronavirus disease-2019 (COVID-19)”, Clinica Chimica Acta; International Journal of Clinical Chemistry510, p. 35–46. doi:10.1016/j.cca.2020.06.045.
(August 2020) “Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases”, Radiology296 (2), p. E32–E40. doi:10.1148/radiol.2020200642.
(July 2020) “Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients”, AJR. American Journal of Roentgenology215 (1), p. 87–93. doi:10.2214/AJR.20.23034.
(November 2020) “Laboratory diagnosis of coronavirus disease-2019 (COVID-19)”, Clinica Chimica Acta; International Journal of Clinical Chemistry510, p. 35–46. doi:10.1016/j.cca.2020.06.045.
(December 2020) “Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples”, Clinical Infectious Diseases71 (10), p. 2663–2666. doi:10.1093/cid/ciaa638.
(July 2020) “Drug treatments for covid-19: living systematic review and network meta-analysis”, BMJ370, p. m2980. doi:10.1136/bmj.m2980.
(February 2020) “Q&A: The novel coronavirus outbreak causing COVID-19”, BMC Medicine18 (1), p. 57. doi:10.1186/s12916-020-01533-w.
(March 2020) “Comorbidities and multi-organ injuries in the treatment of COVID-19”, Lancet395 (10228), p. e52. doi:10.1016/s0140-6736(20)30558-4.
(March 2020) “Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures”, Journal of Medical Virology92 (6), p. 568–576. doi:10.1002/jmv.25748.
(May 2020) “Could nasal breathing help to mitigate the severity of COVID-19”, Microbes and Infection22 (4–5), p. 168–171. doi:10.1016/j.micinf.2020.05.002.
(March 2020) “Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence”, International Journal of Antimicrobial Agents55 (6), p. 105948. doi:10.1016/j.ijantimicag.2020.105948.
(November 2020) “Update to living WHO guideline on drugs for covid-19”, BMJ (Clinical Research Ed.)371, p. m4475. doi:10.1136/bmj.m4475.
(April 2020) “COVID-19, ECMO, and lymphopenia: a word of caution”, The Lancet. Respiratory Medicine8 (4), p. e24. doi:10.1016/s2213-2600(20)30119-3.
(2021) “Immunopathogenesis and treatment of cytokine storm in COVID-19”, Theranostics11 (1), p. 316–329. doi:10.7150/thno.49713.
(December 2020) “Therapy for Early COVID-19: A Critical Need”, JAMA324 (21), p. 2149–2150. doi:10.1001/jama.2020.22813.
(November 2020) “Covid-19: What now for remdesivir?”, BMJ371, p. m4457. doi:10.1136/bmj.m4457.
(April 2020) “2019 Novel coronavirus: where we are and what we know”, Infection48 (2), p. 155–163. doi:10.1007/s15010-020-01401-y.
(October 2020) “Will covid-19 vaccines save lives? Current trials aren't designed to tell us”, BMJ371, p. m4037. doi:10.1136/bmj.m4037.
(December 1975) “Letter: Acid secretion by gastric mucous membrane”, The American Journal of Physiology229 (6), p. 21–25. doi:10.1080/03007995.2020.1853510.
(October 2020) “Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19)”, Seminars in Thrombosis and Hemostasis46 (7), p. 845–849. doi:10.1055/s-0040-1715458.
(November 2020) “Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission – United States, March-August 2020”, MMWR. Morbidity and Mortality Weekly Report69 (45), p. 1695–1699. doi:10.15585/mmwr.mm6945e2.
(March 2020) “COVID-19 and smoking: A systematic review of the evidence”, Tobacco Induced Diseases18, p. 20. doi:10.18332/tid/119324.
(August 2020) “Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking”, Environmental Toxicology and Pharmacology78, p. 103411. doi:10.1016/j.etap.2020.103411.
(June 2021) “Early Spread of COVID-19 in the Air-Polluted Regions of Eight Severely Affected Countries”, Atmosphere (en) 12 (6), p. 795. doi:10.3390/atmos12060795.
(June 2020) “Air Pollution and Covid-19: The Role of Particulate Matter in the Spread and Increase of Covid-19's Morbidity and Mortality”, International Journal of Environmental Research and Public Health17 (12), p. 4487. doi:10.3390/ijerph17124487.
(July 2020) “Obesity – A risk factor for increased COVID-19, severity and lethality (Review)”, Molecular Medicine Reports22 (1), p. 9–19. doi:10.3892/mmr.2020.11127.
(November 2020) “COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From Belgium”, Kidney Medicine2 (4), p. 459–466. doi:10.1016/j.xkme.2020.06.001.
(April 2021) “Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity”, Nature Genetics53 (6), p. 801–808. doi:10.1038/s41588-021-00854-7.
(October 2020) “Autoantibodies against type I IFNs in patients with life-threatening COVID-19”, Science370 (6515), p. eabd4585. doi:10.1126/science.abd4585.
(June 2013) “A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication”, Gastroenterology144 (7), p. 1438–49, 1449.e1–9. doi:10.1053/j.gastro.2013.02.026.
(September 2020) “COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study”, The Lancet. Child & Adolescent Health4 (9), p. 653–661. doi:10.1016/S2352-4642(20)30177-2.
(April 2020) “Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?”, The Lancet. Respiratory Medicine8 (4), p. e21. doi:10.1016/S0140-6736(20)30311-1.
(February 2020) “The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China”, International Journal of Infectious Diseases91, p. 264–266. doi:10.1016/j.ijid.2020.01.009.
(April 2020) “Care for Critically Ill Patients With COVID-19”, JAMA323 (15), p. 1499–1500. doi:10.1001/jama.2020.3633.
(June 2021) “Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis”, Journal of Clinical Medicine10 (11), p. 2490. doi:10.3390/jcm10112490.
(November 2020) “Arrhythmia in patients with severe coronavirus disease (COVID-19): a meta-analysis”, European Review for Medical and Pharmacological Sciences24 (21), p. 11395–11401. doi:10.26355/eurrev_202011_23632.
(July 2020) “Cardiovascular complications in COVID-19”, The American Journal of Emergency Medicine38 (7), p. 1504–1507. doi:10.1016/j.ajem.2020.04.048.
(November 2020) “Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)”, JAMA Cardiology5 (11), p. 1265–1273. doi:10.1001/jamacardio.2020.3557.
(November 2020) “Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases”, JAMA Cardiology5 (11), p. 1281–1285. doi:10.1001/jamacardio.2020.3551.
(September 2020) “Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management”, Heart Rhythm17 (9), p. 1463–1471. doi:10.1016/j.hrthm.2020.05.001.
(May 2020) “Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review”, JAMA323 (18), p. 1824–1836. doi:10.1001/jama.2020.6019.
(May 2020) “Neurological complications of coronavirus and COVID-19”, Revista de Neurología70 (9), p. 311–322. doi:10.33588/rn.7009.2020179.
(February 2020) “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”, Lancet395 (10223), p. 497–506. doi:10.1016/S0140-6736(20)30183-5.
(November 2020) “Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis”, Pulmonology27 (4), p. 328–337. doi:10.1016/j.pulmoe.2020.10.013.
(January 2021) “The lingering manifestations of COVID-19 during and after convalescence: update on long-term pulmonary consequences of coronavirus disease 2019 (COVID-19)”, La Radiologia Medica126 (1), p. 40–46. doi:10.1007/s11547-020-01295-8.
(August 2020) “Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery”, EClinicalMedicine25, p. 100463. doi:10.1016/j.ijtb.2020.11.003.
Oran, Daniel P., and Eric J. Topol. “Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.” Annals of Internal Medicine. vol. 173,5 (2020): 362-367. doi:10.7326/M20-3012 PMID 32491919 Retrieved 14 January 2021.
Sandra Haber, Baxter Parolas!Baxter speaks! , eld. Mondial, 2023, 59 paĝoj. Novelo pri hundo kun misio kreskigi internacian pacon. Kun ilustraĵoj de la aŭtorino, trad. R.J. García, Libroservo de Universala Esperanto-Asocio, ISBN 9781595694676.